Gate Neurosciences
Manufacturing · Indiana, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1210 Waterway Blvd, Indianapolis, Indian...Website
www.gateneuro.comRevenue
<$5 MillionIndustry
About Gate Neurosciences
Gate Neurosciences Org Chart
Is Gate Neurosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Gate Neurosciences had a recent Job posting/layoffs
Gate Neurosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Gate Neurosciences
Funding: Get notified immidiatlly once Gate Neurosciences has new funding data
Website visits: Recent activity has been detected on your website
Check out if Gate Neurosciences is spiking on competitors!
Product Launch: Get notified when Gate Neurosciences launches new products
Earning: See what the market has to say on Gate Neurosciences recently announced quarterly report
Check if Gate Neurosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Gate Neurosciences
Find more new buyers
Compare Similar Companies to Gate Neurosciences
Compare insights from companies similar to Gate Neurosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gate Neurosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gate Neurosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gate Neurosciences.
Gate Neurosciences Tech Stack
A closer look at the technologies used by Gate Neurosciences
Gate Neurosciences News & Media
Gate Neurosciences Presents New Data and Insights Highlighting Unique Pharmacology of Synaptic Function Modulators at the 2024 ACNP Annual Meeting
INDIANAPOLIS--(BUSINESS WIRE)--Gate's two poster presentations at ACNP highlight new research on the fundamental biology of molecules targeting synaptic function in CNS diseaseGate Neurosciences and University of Pittsburgh Collaborate to Initiate Phase 2 Trial Combining Apimostinel with Digital Therapeutic for Depression
INDIANAPOLIS--(BUSINESS WIRE)--The Phase 2 study will explore a digital neurocognitive tool's ability to extend the efficacy of apimostinel’s rapid antidepressant effectGate Neurosciences to Share New Data and Research Insights on its Synaptic Function Molecules with Multiple Posters at 2024 ASCP Annual Meeting
INDIANAPOLIS--(BUSINESS WIRE)--Gate will host its 3rd annual R&D Day with investigators and KOLs to share new insights ahead of an upcoming Phase 2 MDD study with zelquistinel.Gate Neurosciences Announces Clinical Collaboration with Beacon Biosignals to Advance Precision EEG Biomarkers in Major Depressive Disorder
INDIANAPOLIS--(BUSINESS WIRE)--Collaboration using Beacon Biosignals’ Dreem 3S device in an upcoming Phase 2 clinical trial of Gate's lead oral program, zelquistinel, in MDD.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gate Neurosciences
We're on a mission to answer the unmet needs of people living with CNS conditions by developing safe, potent, and rapid-acting therapies.... Read More